Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Summary aggregated from TechCrunch's public RSS feed. The full reporting belongs to TechCrunch — please read it on their site.